Assessment of Medication Adherence Using Malaysia Medication Adherence Assessment Tool in a Tertiary Care Hospital in Peshawar, Pakistan
Abstract
Objective: To assess the adherence to medications using Malaysian Medication Adherence Assessment tool in patients suffering from chronic health conditions admitted in a tertiary care hospital.Methods
This cross-sectional study was carried out at in the Department of Internal Medicine, Hayatabad Medical Complex, Peshawar, from 1st January to 31st March, 2023. All the patients admitted having chronic medical conditions were included, using convenient non-probability sampling technique. Medication adherence was assessed by adopting Malaysia Medication Adherence Assessment Tool using five-point Likert scale.The higher the score, the better the adherence with the medications with a mean cut-off of 54 for the poor and good adherence. All the variables were analysed and respective frequency and percentages were calculated. Non-compliance with the medications was compared and correlated with rest of the variables by using chi-square test and p-value ≤0.05 was considered as significant.Results
 A total of 201 patients were included having mean age of 56.27 ± 16.48 years, with 108 (54.2%) females and 92(45.8%) males. The general frequency of non-adherence was observed in 59%. The mean MyMAAT Score cut-off of ≤ 53 (poor adherence) for the non-compliance was reported in all the included individuals. Further stratification of the noncompliance was analysed for age, acquired education, monthly income, profession and gender and we observed no statistically significant difference.Conclusion
 We observed a high prevalence of medications non-adherence in our limited pilot study and requires large multi-centre studies with good representation from all segments to know the factors causing non-adherence, guiding the further strategies for improvement.Keywords:
MedicationsAdherence, Non-compliance, MedicationsPublished
2024/06/07
Issue
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments psimjournal@gmail.com